TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM

Clinical trial NCT02202993 · COMPLETED

Trial details

NCT number: NCT02202993
Sponsor: Cavion, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme (GBM)

Start date: 2014-08-01
Primary completion: 2017-09-29
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.